Edition:
United States

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

4.44USD
23 Sep 2016
Change (% chg)

$-0.08 (-1.77%)
Prev Close
$4.52
Open
$4.54
Day's High
$4.54
Day's Low
$4.41
Volume
2,915
Avg. Vol
18,293
52-wk High
$6.84
52-wk Low
$2.70

SNSS.OQ

Chart for SNSS.OQ

About

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company offers QINPREZO (vosaroxin), which is a product candidate for the treatment of acute myeloid leukemia... (more)

Overall

Beta: 1.65
Market Cap(Mil.): $64.39
Shares Outstanding(Mil.): 14.50
Dividend: --
Yield (%): --

Financials

  SNSS.OQ Industry Sector
P/E (TTM): -- 42.52 36.60
EPS (TTM): -2.89 -- --
ROI: -170.08 -0.26 13.91
ROE: -725.86 -3.05 14.82

BRIEF-Sunesis Pharmaceuticals announces 1-for-6 reverse stock split

* Sunesis Pharmaceuticals-announces 1-for-6 reverse stock split

Sep 07 2016

BRIEF-Sunesis Pharmaceuticals Q1 revenue $600,000

* Sunesis Pharmaceuticals reports first quarter 2016 financial results and recent highlights

May 05 2016

BRIEF-Sunesis pharmaceuticals says it entered into a loan and security agreement

* Says on March 31, 2016 co entered into loan and security agreement with Western Alliance Bank and Solar Capital Ltd

Apr 06 2016

Competitors

  Price Chg
Eisai Co., Ltd (4523.T) ¥6,485 -41.00
Johnson & Johnson (JNJ.N) $118.81 -0.65
Novartis AG (NOVN.S) CHF79.15 -0.10
Pfizer Inc. (PFE.N) $34.26 +0.11
Merck & Co., Inc. (MRK.N) $62.96 -0.06
Celgene Corporation (CELG.OQ) $109.43 -1.14

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.